Search

Background and PurposeA NO-mediated desensitization of vasoconstrictor responses evoked by stimulation of (1)-adrenoceptors has been reported in different vessels. We investigated the involvement of each (1)-adrenoceptor subtype and constitutive NOS isoforms and the influence of ageing and hypertension on this process. Experimental ApproachWistar and spontaneously hypertensive rats (SHR), 16, 32, 52 and 72weeks-old, were used to evaluate the desensitization process. Expression of (1)-adrenoceptor subtypes, endothelial NOS (eNOS) and neuronal NOS (nNOS) were determined in rat aorta and left ventricle (LV). Expression levels were also evaluated in LV of a group of heart failure patients with a wide age range. Key ResultsRepeated application of phenylephrine decreased subsequent (1)-adrenoceptor-mediated vasoconstriction by increasing nNOS protein expression in aorta, but not in tail or mesenteric resistance arteries, where mRNA levels of nNOS were undetectable. This desensitization process disappeared in the absence of endothelium or in the presence of L-NAME (100M), nNOS inhibitors, SMTC (1M) and TRIM (100M), and 5-methylurapidil (100nM, (1A)-antagonist), but not BMY7378 (10nM, (1D)-antagonist). The (1A)/nNOS-mediated desensitization was absent in aged SHR and Wistar animals, where the expression of (1A)-adrenoceptors was reduced in aorta and LV. In human LV, a negative correlation was found between age and (1A)-adrenoceptor expression. Conclusions and ImplicationsThe (1A)-adrenoceptor subtype, through endothelial nNOS-derived NO, may act as a physiological brake' against the detrimental effects of excessive (1)-adrenoceptor-mediated vasoconstriction. Reduced (1A)-adrenoceptor- and nNOS-mediated desensitization in aged patients could be involved in the age-dependent elevation of adrenergic activity.